Sign in
Taking peopleNo phase

Home-based gentle brain and nerve stimulation for children with cerebral palsy

Tests a home stimulation device in children and teenagers with cerebral palsy.

Key facts

Who runs it
KK Women's and Children's Hospital
Where
Singapore2 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
A Novel Home-based Non-invasive Neuromodulation Therapy for Children and Adolescents With Cerebral Palsy
Status
Recruiting
People taking part
60 people, planned
Started
11 Oct 2024
Planned end
Nov 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • AscenZ-IV neuromodulation device
Record updated
10 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and young people with spastic cerebral palsy to test a home-based brain and nerve stimulation device (AscenZ-IV Stimulator). Families, staff and clinicians may join interviews.

Age
The criteria say 2 to under 21 years. The registry age fields say 6 Years to 21 Years.
Sex
All sexes can join.
Disease stage
Mild to severe spastic cerebral palsy, Gross Motor Function Classification System (GMFCS) level II, III, IV or V.
Earlier treatment
No botulinum toxin injections into muscle within the last 6 months. No muscle, bone, brain or nerve surgery within the last 6 months. No major surgery with a hospital stay over 1 week within the last 3 months.

Main reasons for not taking part

  • Epilepsy with a seizure in the last 12 months, or uncontrolled epilepsy
  • History of brain tumour, brain injury or mental illness
  • An implanted electrical device such as a pacemaker or defibrillator, or devices affected by magnets such as programmable shunts
  • Pregnancy
  • No parent or caregiver with at least simple English; people who refuse audio recording cannot join the interviews

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Children and adolescents aged between 2 to <21 years old with mild to severe Spastic Cerebral Palsy (CP) classified on Gross Motor Function Classification System (GMFCS) II, III, IV, V. Families with at least one parent or caregiver has simple or conversational English language skill
  • To be eligible for the qualitative interview components of this research study, the individuals should be recognised as one of the following:
  • CP patients who participate in this research study,
  • caregivers of the CP patients taking part in this research study,
  • implementation staff
  • qualified clinicians not involved in the intervention or refused to recommend the intervention device (AscenZion-IV stimulator) for management of CP; Eligible individuals must agree to be audio-recorded

Who cannot take part

  • CP patients who received any intramuscular botulinum toxin injections within less than 6 months (as anti-spasticity effect lasts for 4-6 months)
  • CP patients who received any musculo-skeletal, brain or nerve-related surgery within less than 6 months, or major surgery requiring prolonged hospitalisation (\&gt;1week) within less than 3 months; Those who do not agree to be audio-recorded will be excluded for the qualitative interview components of this research study
  • CP patients with epilepsy with recent seizures (\&lt;12 months) will be excluded for safety given the theoretical risks of seizures (abnormal brain electrical discharges) with transcranial electrical stimulation. We will include those with well controlled epilepsy with no recent seizures (within 12 months)
  • CP patients who have contra-indications to the use of tPCS and/or TENS will be excluded from the study, include:; Individuals with history of uncontrolled epileptic disorder, seizures, brain tumour or trauma, and mental disease; Individuals with electrical implanted stimulatory device, such as pacemaker or defibrillator; Individuals with medical devices that are affected by magnets, such as programmable shunts; Individuals with pregnancy

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 6 and 21 years old?

This trial is currently available in Singapore.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to evaluate the clinical effectiveness, feasibility and acceptability of a novel home-based noninvasive neuromodulation therapy (AscenZ-IV Stimulator) that utilizes transcranial Pulse Current Stimulation (tPCS) and Transcutaneous Electrical Nerve Stimulation (TENS) for children and adolescents with cerebral palsy as a community-based intervention by families and healthcare providers.

The 2 groups in the trial

  • Intervention: Standard care + AscenZ-IV StimulationTreatment being tested

    Participants randomized as Group 1 first receive both standard care (existing medical interventions, therapy program) and AscenZ-IV Stimulation for 8 weeks (30min/day; 5 to 7 sessions/week, additional 30min/day; 5 to 7 sessions/week for behavioral and drooling issues if necessary). Then, they receive standard care only for another 8 weeks. For participants randomized as Group 2, control condition precedes intervention condition. Subsequently, participants are given the option to receive an additional 4 weeks of intervention for maintenance

    Treatment: AscenZ-IV neuromodulation device

  • Control: Standard care onlyNo study treatment, for comparison

    Participants randomized as Group 1 first receive both standard care (existing medical interventions, therapy program) and AscenZ-IV Stimulation for 8 weeks (30min/day; 5 to 7 sessions/week, additional 30min/day; 5 to 7 sessions/week for behavioral and drooling issues if necessary). Then, they receive standard care only for another 8 weeks. For participants randomized as Group 2, control condition precedes intervention condition. Subsequently, participants are given the option to receive an additional 4 weeks of intervention for maintenance

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Novel Home-based Non-invasive Neuromodulation Therapy for Children and Adolescents With Cerebral Palsy
Plain-language title
Home-based gentle brain and nerve stimulation for children with cerebral palsyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06921538, who can take part
Record updated
10 April 2025